Clinical Trial Update: Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER [Phase 4]

View source ↗

Summary

A Phase 4 study assessing early prediction of clinical response to paliperidone ER in patients with schizophrenia (and schizoaffective disorder) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Taipei City Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED